Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 39 Brain Neoplasms 17 Astrocytoma 16 Central Nervous System Neoplasms 9 Oligodendroglioma 8 Gliosarcoma 8 Melanoma 7 Glioma 7 Neoplasms 5 Recurrence 4 Neoplasm Metastasis 3 Neuroblastoma 2 Ganglioneuroblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Choroid Plexus Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Sarcoma, Ewing 1 Sarcoma 1 Rhabdoid Tumor 1 Rare Diseases 1 Optic Nerve Glioma 1 Neurotoxicity Syndromes 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Neuroepithelial 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms, Bone Tissue 1 Neoplasms by Histologic Type 1 Melanoma, Cutaneous Malignant 1

Interventions

Fluorouracil 72 Leucovorin 71 Oxaliplatin 47 Irinotecan 31 Capecitabine 24 Bevacizumab 23 Folfox protocol 20 Cetuximab 15 Chemotherapy, Adjuvant 13 Celecoxib 7 Aspirin 6 Laparoscopy 5 XELOX 4 Panitumumab 4 Neoadjuvant Therapy 4 Levamisole 4 dehydroftorafur 3 Tegafur 3 Surgical Procedures, Operative 3 Observation 3 Floxuridine 3 vatalanib 2 tislelizumab 2 pertuzumab 2 encorafenib 2 atezolizumab 2 Trastuzumab 2 Standard of Care 2 Semaxinib 2 Selenium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colonic Neoplasms × Temozolomide × Clear all

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡